ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

ImageneBio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

ImageneBio's total debt was $0 at Dec 31, 2025. For fiscal 2025 it was $0, down 100.0% from the year before.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$0	-100.0%
FY2024	Dec 31, 2024	$7.50M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2025	Dec 31, 2025	$0	–
Q3 FY2025	Sep 30, 2025	$0	–
Q4 FY2024	Dec 31, 2024	$7.50M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMA.

Advertisement
300 × 250

See a number that looks wrong?